New hope for kids with aggressive cancer: tailored therapy trial launches

NCT ID NCT02559778

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for children newly diagnosed with high-risk neuroblastoma, a rare and aggressive nerve cancer. It uses genetic testing to choose personalized chemotherapy, then tests whether adding the drug DFMO to standard immunotherapy helps prevent relapse. About 500 children will take part to see if this approach improves how long they stay cancer-free.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advocate Aurora Research Institute

    COMPLETED

    Chicago, Illinois, 60453, United States

  • Alberta Children's Hospital

    RECRUITING

    Calgary, Alberta, AB T3B 6A8, Canada

  • Arkansas Children's Hospital

    RECRUITING

    Little Rock, Arkansas, 72202, United States

  • Arnold Palmer Hospital for Children

    RECRUITING

    Orlando, Florida, 32806, United States

  • Augusta University Health

    RECRUITING

    Augusta, Georgia, 30912, United States

  • CHU Sainte-Justine

    RECRUITING

    Montreal, Quebec, QC H3S 2G4, Canada

  • CHUQ

    RECRUITING

    Québec, Quebec, QC G1V 4W6, Canada

  • CIUSSS de l'Estrie-CHUS

    RECRUITING

    Sherbrooke, Quebec, QC J1H 5H3, Canada

  • Cardinal Glennon Children's Medical Center

    RECRUITING

    St Louis, Missouri, 63104, United States

  • Children's Hospital and Clinics of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55404, United States

  • Children's Medical Center

    RECRUITING

    Dallas, Texas, 75235, United States

  • Children's Mercy Hospitals and Clinics

    COMPLETED

    Kansas City, Missouri, 64108, United States

  • Connecticut Children's Hospital

    RECRUITING

    Hartford, Connecticut, 06106, United States

  • Dell Children's Blood and Cancer Center

    RECRUITING

    Austin, Texas, 78723, United States

  • Hackensack University Medical Center

    COMPLETED

    Hackensack, New Jersey, 07601, United States

  • Helen DeVos Children's Hospital

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Kapiolani Medical Center for Women and Children

    RECRUITING

    Honolulu, Hawaii, 96813, United States

  • Levine Children's Hospital

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Nicklaus Children's Miami

    RECRUITING

    Miami, Florida, 33155, United States

  • Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • Penn State Milton S. Hershey Medical Center and Children's Hospital

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Rady Children's Hospital

    RECRUITING

    San Diego, California, 92123, United States

  • Randall Children's Hospital

    RECRUITING

    Portland, Oregon, 97227, United States

  • St. Joseph's Children's Hospital

    RECRUITING

    Tampa, Florida, 33614, United States

  • St. Lukes

    COMPLETED

    Boise, Idaho, 83712, United States

  • UCSF Benioff Children's Hospital Oakland

    RECRUITING

    Oakland, California, 94609, United States

  • University of Alabama/Children's of Alabama

    RECRUITING

    Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.